TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05361564 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05361564 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05638867 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06054776 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06513169 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05105295 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05994131 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05551858 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT05263271 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT05263271 — Predictive Biomarker (PRD): SIRPA mRNA
Genes: SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP
Study NCT04087538 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT06026241 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04653285 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04653285 — Safety Biomarker (SAF): BDNF
Study NCT06154044 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04735068 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06151444 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06666270 — Predictive Biomarker (PRD): POLQ mRNA
Genes: POLQ; POLH
Study NCT05952804 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06532630 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04695223 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT04695223 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05453552 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05202678 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05442047 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT05812001 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05812001 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05812001 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06683131 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05141552 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06682585 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04779762 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04779762 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study NCT05973760 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06653062 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT05996835 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06143592 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT05280626 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06667960 — Predictive Biomarker (PRD): TPBG mRNA
Genes: TPBG; 5T4
Study NCT06670950 — Predictive Biomarker (PRD): SYT1 mRNA
Genes: SYT1; SVP65; SYT
Study NCT06346639 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06192849 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05371925 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT05577923 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05419024 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05073133 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT06007183 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06729008 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06729008 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT06478017 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT05923814 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT05424016 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT05424016 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06703216 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06732180 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT06734832 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06750523 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06752577 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06753981 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06752863 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06601478 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06754501 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT06755619 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06754293 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06125314 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05029869 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05104489 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05941637 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT05941637 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06127693 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05495321 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05156658 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT05816850 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT05873868 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT03901001 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03901001 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03901001 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03901001 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT05728723 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06024486 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05279859 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT05690997 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05539443 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06509919 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03887741 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06132113 — Predictive Biomarker (PRD): DLL3 mRNA
Genes: DLL3
Study NCT06213766 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT00780728 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05687474 — Predictive Biomarker (PRD): NBN mRNA
Genes: NBN; NBS; NBS1; P95
Study NCT06372925 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06418594 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06418594 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06360393 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04947696 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05146219 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04903288 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study NCT04903288 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study NCT05398809 — Predictive Biomarker (PRD): AIRE mRNA
Genes: AIRE; APECED
Study NCT04936035 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Angiotensinogen
Genes: AGT; SERPINA8
Study NCT04936035 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06482996 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06331884 — Predictive Biomarker (PRD): DPP3 mRNA
Genes: DPP3
Study NCT06725953 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06725953 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT05639608 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04990362 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05894824 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04996706 — Predictive Biomarker (PRD): RTEL1 mRNA
Genes: RTEL1; C20orf41; KIAA1088; NHL
Study NCT05677971 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT05754450 — Predictive Biomarker (PRD): SLC35C1 mRNA
Genes: SLC35C1; FUCT1
Study NCT05716295 — Predictive Biomarker (PRD): MDK mRNA
Genes: MDK; MK1; NEGF2
Study NCT06401447 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04765657 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04765657 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06150092 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT05300282 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05453773 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT05453773 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06316856 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study NCT04345250 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT05071053 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05667246 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00002277 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT06414434 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT04822792 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04604951 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04890171 — Predictive Biomarker (PRD): ESD mRNA
Genes: ESD
Study NCT06311708 — Predictive Biomarker (PRD): PKP2 mRNA
Genes: PKP2
Study NCT05351320 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05351320 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06003322 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05960604 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04939129 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05292768 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT04662060 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05594979 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT05347836 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT06758531 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06758531 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06758531 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06757439 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04756687 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06073002 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05842759 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06645808 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT06670989 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06627920 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06757608 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05127980 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT06715852 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06728267 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06727604 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT05876507 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06395051 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT06753149 — Predictive Biomarker (PRD): ABCC3 mRNA
Genes: ABCC3; CMOAT2; MLP2; MRP3
Study NCT06753149 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT05548517 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06408038 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT06752681 — Predictive Biomarker (PRD): PTK7 mRNA
Genes: PTK7; CCK4
Study NCT06754059 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06446154 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06175793 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05208047 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04774718 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06206408 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06145542 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06398613 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04995536 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT05568537 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05419011 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05419011 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT06317753 — Safety Biomarker (SAF): BDNF
Study NCT05198960 — Predictive Biomarker (PRD): CALR mRNA
Genes: CALR; CRTC
Study NCT05198960 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT05217667 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study NCT06299878 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05734105 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT02142868 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02142868 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02142868 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04912687 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04912687 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04907019 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01235013 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01235013 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT06381453 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study NCT05706506 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT06400485 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT06258967 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06400069 — Predictive Biomarker (PRD): NLRP6 mRNA
Genes: NLRP6; NALP6; PYPAF5
Study NCT05121740 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06195930 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05049382 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05049382 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05380557 — Predictive Biomarker (PRD): DCLRE1C mRNA
Genes: DCLRE1C; ARTEMIS; ASCID; SCIDA; SNM1C
Study NCT05278169 — Predictive Biomarker (PRD): PLXNA2 mRNA
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study NCT06136624 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06471595 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06502990 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05642715 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05642715 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05669339 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06433778 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04066348 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05137665 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05137665 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06580717 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06047977 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT06047977 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05939830 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05691478 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04837807 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT00001005 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05258136 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05526131 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06109779 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT05113251 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05525702 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06145438 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05079698 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05447650 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05037695 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05037695 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05061420 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06728995 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06727942 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study NCT05648201 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT05821556 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT05914870 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06482359 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05107557 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05268679 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05268679 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05604547 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05604547 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05172596 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05849480 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT06112314 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05179070 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05510427 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT06372587 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05888558 — Safety Biomarker (SAF): miR-340-5p
Genes: MIR340
Study NCT05888558 — Predictive Biomarker (PRD): miR-106b
Genes: MIR106B
Study NCT04555785 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT06257017 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05926453 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06224062 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06530394 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06677502 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04795245 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04795245 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05613426 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05613426 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04866017 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06701357 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT06701357 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT06720662 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06720662 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05716074 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05762276 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05762276 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05214183 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05214183 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06749041 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04892264 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06340477 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06749639 — Predictive Biomarker (PRD): RDH12 mRNA
Genes: RDH12; SDR7C2
Study NCT06755138 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05846490 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05507840 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06754800 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04806204 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04920643 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05494957 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT06755372 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT05946564 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06755567 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05682638 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04819243 — Predictive Biomarker (PRD): HR mRNA
Genes: HR